{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:58:09Z","timestamp":1761155889729,"version":"3.37.3"},"reference-count":9,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":274,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/cei.12520","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T12:43:26Z","timestamp":1419857006000},"page":"78-82","source":"Crossref","is-referenced-by-count":6,"special_numbering":"supplement S1","title":["Considering the demand for and prioritization of intravenous immunoglobulin"],"prefix":"10.1093","volume":"178","author":[{"given":"J. S.","family":"Orange","sequence":"first","affiliation":[{"name":"Texas Children's Hospital; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"10.1111\/cei.12520-BIB0001|cei12520-cit-0001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-013-9975-1","article-title":"Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin","volume":"34","author":"Stonebraker","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1111\/cei.12520-BIB0002|cei12520-cit-0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12026-014-8498-z","article-title":"Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery","volume":"60","author":"Modell","year":"2014","journal-title":"Immunol Res"},{"key":"10.1111\/cei.12520-BIB0003|cei12520-cit-0003","article-title":"Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project","author":"Holding","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/cei.12520-BIB0004|cei12520-cit-0004","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/cei.12369","article-title":"Calculated globulin (CG) as a screening test for antibody deficiency","volume":"177","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/cei.12520-BIB0005|cei12520-cit-0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2249.2012.04594.x","article-title":"Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy","volume":"169","author":"Orange","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/cei.12520-BIB0006|cei12520-cit-0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1111\/cei.12520-BIB0007|cei12520-cit-0007","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/cei.12520-BIB0008|cei12520-cit-0008","unstructured":"Immune Deficiency Foundation survey of hospital pharmacy directors 2006 http:\/\/primaryimmune.org\/idf-survey-research-center\/idf-surveys\/ivig-access-surveys\/?aid=1369&sa=1"},{"key":"10.1111\/cei.12520-BIB0009|cei12520-cit-0009","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10875-013-9912-3","article-title":"Prioritization of evidence-based indications for intravenous immunoglobulin","volume":"33","author":"Orange","year":"2013","journal-title":"J Clin Immunol"}],"container-title":["Clinical & Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12520","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cei.12520\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:23Z","timestamp":1641054443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cei.12520"}},"subtitle":["Prioritization of intravenous immunoglobulin"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1111\/cei.12520","archive":["Portico"],"relation":{},"ISSN":["0009-9104"],"issn-type":[{"type":"print","value":"0009-9104"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}